首页> 外文期刊>Retina >Retinal angiomatous proliferation: natural history and progression of visual loss.
【24h】

Retinal angiomatous proliferation: natural history and progression of visual loss.

机译:视网膜血管瘤增生:自然史和视力丧失进展。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To investigate the natural history and visual outcome in eyes with untreated retinal angiomatous proliferation, a neovascular form of age-related macular degeneration. METHODS: Fourteen consecutive white patients (11 women, 78%; mean age, 74 years) with 16 eyes affected by retinal angiomatous proliferation were prospectively followed-up without treatment by means of complete ophthalmologic examinations at regular intervals, including best-corrected visual acuity and dynamic fluorescein and indocyanine green angiography using a scanning laser ophthalmoscope. RESULTS: The patients were observed for a mean of 20 months (range, 6-44 months). Mean visual acuity in the eyes with retinal angiomatous proliferation was 0.48 at the initial examination, decreased to 0.23 after 6 months, and was 0.19 at the final examination, with a mean decrease of 6 lines from baseline. In 13 eyes (81%), visual acuity deteriorated by 2 Early Treatment Diabetic Retinopathy Study lines or worse by the time of the 6-month examination, and 31% of the patients had experienced severe loss of vision; the remaining 3 eyes (19%) showed a relatively stable clinical course and visual acuity. By the time of the final examination, visual acuity had decreased to 0.1 or worse in 11 eyes (69%), and 5 of the 14 patients (36%) were legally blind. At the final examination, 10 eyes (62%) showed a subretinal fibrosis and 9 (56%) showed a retinal choroidal anastomosis. CONCLUSION: Retinal angiomatous proliferation is a distinct form of neovascular age-related macular degeneration with high vasogenic potential, having its own clinical course and visual prognosis. The poor visual outcome is because of the exudative nature of the retinal angiomatous proliferation, and progression to poor vision is common and rapid (within 3 months in faster cases, and within 1 year in slower cases). The treatment options for this type of neovascular lesion should be planned bearing in mind its unfavorable natural history.
机译:目的:研究未经治疗的视网膜血管瘤增生(一种与年龄有关的黄斑变性的新血管形式)的眼睛的自然病史和视觉结果。方法:对14例连续16年受视网膜血管瘤增生影响的16眼白人患者(11例女性,平均年龄74岁)进行了随访,不进行定期的完整眼科检查,包括最佳矫正视力,无需治疗扫描激光检眼镜和动态荧光素和吲哚菁绿血管造影。结果:患者平均观察20个月(范围6-44个月)。视网膜血管瘤增生的眼睛的平均视力在最初检查时为0.48,在6个月后降至0.23,在最终检查时为0.19,与基线相比平均下降了6行。在13眼(81%)中,视力因2项早期糖尿病视网膜病变研究线而恶化,或在6个月检查时恶化,并且31%的患者出现了严重的视力丧失;其余3眼(19%)显示相对稳定的临床病程和视力。到最后检查时,11眼(69%)的视力下降到0.1或更差,并且14例患者中有5例(36%)合法失明。在最终检查中,有10眼(62%)表现为视网膜下纤维化,有9眼(56%)表现为视网膜脉络膜吻合。结论:视网膜血管瘤增生是新生血管性黄斑变性的一种独特形式,具有高度的血管生成潜力,具有自己的临床过程和视觉预后。视力不佳的原因是视网膜血管瘤增生的渗出性,并且视力低下是普遍且迅速的(在较快的病例中为3个月,在较慢的病例中为1年内)。考虑到其不利的自然病史,应计划针对此类新血管病变的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号